Latest Vivo Bio Tech stock price

Vivo Bio Tech P/E Ratio

VIVOBIOT • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
6.67
Low Valuation
Very Low - Potentially undervalued or facing challenges

Current Valuation Metrics

P/E Ratio 6.67
Current Price ₹31.74
EPS (TTM) ₹4.76
Exchange BSE

Valuation Signal

Signal Undervalued
Historical Avg 17.06
Historical Range 7.95 - 30.44
Percentile 0.0%

Sector Context

Sector Average 57.32
Sector Median 35.38
Sector Rank #1 of 89
Sector Percentile 1.1%

Earnings Breakdown (TTM)

TTM EPS ₹5.39
Sept 2025 ₹0.45
Mar 2025 ₹0.69

Key P/E Ratio Insights for Vivo Bio Tech

  • Stock appears undervalued with PE of 6.67, suggesting potential buying opportunity
  • Current PE is 60.9% below historical average
  • Trading at discount to sector average PE of 57.32

View the VIVOBIOT equity price for detailed stock performance.

P/E Ratio Historical Trend for Vivo Bio Tech

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 7.95 4.67 ₹37.13 BSE Low
2023 12.78 2.59 ₹33.10 BSE Low
2021 30.44 2.26 ₹68.80 BSE High

Sector P/E Ratio Comparison

Comparing Vivo Bio Tech with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate